Search results | pain

Reports

Pain Partnering

The Pain Partnering provides understanding and access to the pain partnering deals and agreements entered into by the worlds leading healthcare companies

Neuropathy Partnering

The Neuropathy Partnering 2009-2014 report provides understanding and access to the neuropathy partnering deals and agreements entered into by the worlds leading healthcare companies.

Cancer Symptoms Partnering

The Cancer Symptoms Partnering report provides understanding and access to the cancer symptoms partnering deals and agreements entered into by the worlds leading healthcare companies.

Spinal Cord Partnering

The Spinal Cord Partnering provides understanding and access to the spinal cord partnering deals and agreements entered into by the worlds leading healthcare companies

Insights

Purdue Pharma: Perfectionists in pain and partnering

US based Purdue Pharma is a top 50 pharma company specialising in the research and development of prescription and OTC pain treatments.

Endo Health in talks with potential pharma partners for its pain relief medication

Endo Health’s talks with potential pharma partners included parties such as Warner Chilcott and Valeant Pharmaceuticals International Inc  according to the sources. Endo announced in December its longtime chief executive, David Holveck, would retire in 2013.

NeurogesX seeks pharma partners for pain drugs

NeurogesX, a specialty pharmaceutical company is seeking pharma partners for its lead product candidate NGX-1998 in US and other global markets

Xenon collaborates with Genentech for discovery of targeted pain therapeutics and diagnostics

Genentech and Xenon will collaborate in the development of novel targeted pain therapeutics as well in the development of associated companion diagnostics

M&A news: who will win the bidding race?

M&A news: The Canadian pharma company Valeant Pharmaceuticals is rumoured to be raising money to make a bid for specialty drugmaker Salix Pharmaceuticals, according to Bloomberg, which cites people familiar with the matter.

Aspen Pharmacare – Africa’s biggest generic drugmaker

Aspen Pharmacare specialises in the production of branded and generic pharmaceuticals and is currently the biggest pharmaceutical company in South Africa taking a 15% share of the total market.

Both, Actavis and Sanofi competing for Omega Pharma

Several companies are rumored to be competing to acquire Omega Pharma, the fastest growing consumer healthcare company in the U.K. and Ireland.

Nektar Therapeutics: Partnering activity 2009-2014

Nektar Therapeutics is a leading biopharma company headquartered in San Francisco. The company is listed in the top 50 big biotech list by Current Partnering. The company is a world leader in polymer chemistry which involves the design of drugs with optimized drug pharmacology.

Nektar Therapeutics – Well respected partner of choice

Nektar Therapeutics is a leading biopharma company developing clinical stage products based upon its advanced polymer conjugate chemistry technology.

Salix Pharmaceuticals – Getting to grips with gastrointestinal disorders

Specialty Pharmaceuticals Company Salix Pharmaceuticals is committed to providing treatments for a wide spectrum of gastrointestinal disorders.

Events

Sorry, your search returned no results.


Deals

Esteve, Purdue Pharma and Mundipharma in pain pact

Mundipharma Laboratories, Purdue Pharmaceuticals have entered into a global multi programme discovery and development collaboration with Laboratorios Esteve, to bring to market important next generation products for the management of pain

Asset purchase agreement for topical antibiotics and pain products

Actavis has entered into agreements with Akorn and Hi-Tech Pharmacal to purchase four currently marketed products and one product under development for cash consideration.

Acorda big biotech deals for NeurogesX pain assets

Acorda Therapeutics has entered biotech deals with NeurogesX for two neuropathic pain management assets .

Acorda Therapeutics pharma deals with NeurogesX to buy Qutenza pain patch

Big pharma company, Acorda Therapeutics, pharma deals with NeurogesX to buy Qutenza pain patch and a related experimental liquid version of the drug for up to $12 million.

Endo Health in talks with potential pharma partners for its pain relief medication

Endo Health’s talks with potential pharma partners included parties such as Warner Chilcott and Valeant Pharmaceuticals International Inc  according to the sources. Endo announced in December its longtime chief executive, David Holveck, would retire in 2013.

Purdue and ElMindA partnering to develop diagnostics for pain management

The staged research partnering collaboration will focus on pain diagnosis and management

Mayne Pharma enters into pact with GSK for pain reliever Kapanol

Mayne Pharma Group and top pharmaceutical giant GSK penned a pharma partnering agreement which will allow Mayne to acquire rights to pain reliever Kapanol and its related assets in Australia for A$14 million.

A pharma alliances deal for pain drug brings Teva & Xenon Pharmaceuticals closer

Teva Pharmaceutical Industries, one amongst the top pharma enterprise squad collaborated with Xenon Pharmaceuticals in a pharma alliances deal, for co-development and exclusive worldwide license for XEN402.

UniQuest collaborates to advance spider venom pain research

Johnson & Johnson and the University of Queensland will co-develop drugs using components of spider venom as a treatment for chronic pain. The maker of Ultram painkillers will work with Queensland’s Institute of Molecular Bioscience drug development program, the university said in a statement.

Bayer and Almirall enter co-promotion agreement for Xarelto in Spain

Bayer and Almirall announced an agreement to co-promote Rivaroxaban in Spain beginning in the coming months. Rivaroxaban, an oral anticoagulant developed by Bayer, is the only new oral anticoagulant approved in three indications across Europe.